Standard BioTools Inc. (LAB)
Total Valuation
LAB has a market cap or net worth of $1.03 billion. The enterprise value is $1.01 billion.
Market Cap | 1.03B |
Enterprise Value | 1.01B |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, after market close.
Earnings Date | May 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
LAB has 290.12 million shares outstanding. The number of shares has increased by 1.09% in one year.
Shares Outstanding | 290.12M |
Shares Change (YoY) | +1.09% |
Shares Change (QoQ) | +0.74% |
Owned by Insiders (%) | 0.64% |
Owned by Institutions (%) | 56.02% |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 9.67 |
Forward PS | 5.09 |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 9.52 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.45
Current Ratio | 1.45 |
Quick Ratio | 1.23 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -15.25 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -21.50% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | $199,139 |
Profits Per Employee | -$139,805 |
Employee Count | 534 |
Asset Turnover | 0.31 |
Inventory Turnover | 2.66 |
Taxes
In the past 12 months, LAB has paid $452,000 in taxes.
Income Tax | 452,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +32.51% in the last 52 weeks. The beta is 1.63, so LAB's price volatility has been higher than the market average.
Beta (1Y) | 1.63 |
52-Week Price Change | +32.51% |
50-Day Moving Average | 2.48 |
200-Day Moving Average | 2.36 |
Relative Strength Index (RSI) | 57.52 |
Average Volume (30 Days) | 1,875,144 |
Short Selling Information
The latest short interest is 9.26 million, so 3.19% of the outstanding shares have been sold short.
Short Interest | 9.26M |
Short Previous Month | 7.92M |
Short % of Shares Out | 3.19% |
Short % of Float | n/a |
Short Ratio (days to cover) | 4.91 |
Income Statement
In the last 12 months, LAB had revenue of $106.34 million and -$74.66 million in losses. Loss per share was -$0.94.
Revenue | 106.34M |
Gross Profit | 50.45M |
Operating Income | -76.60M |
Pretax Income | -74.20M |
Net Income | -74.66M |
EBITDA | -65.66M |
EBIT | -69.64M |
Loss Per Share | -$0.94 |
Balance Sheet
The company has $114.90 million in cash and $98.21 million in debt, giving a net cash position of $16.69 million or $0.06 per share.
Cash & Cash Equivalents | 114.90M |
Total Debt | 98.21M |
Net Cash | 16.69M |
Net Cash Per Share | $0.06 |
Equity / Book Value | -148.05M |
Book Value Per Share | -0.51 |
Working Capital | 48.89M |
Cash Flow
In the last 12 months, operating cash flow was -$43.29 million and capital expenditures -$2.83 million, giving a free cash flow of -$46.12 million.
Operating Cash Flow | -43.29M |
Capital Expenditures | -2.83M |
Free Cash Flow | -46.12M |
FCF Per Share | -$0.58 |
Margins
Gross margin is 47.44%, with operating and profit margins of -72.03% and -70.21%.
Gross Margin | 47.44% |
Operating Margin | -72.03% |
Pretax Margin | -69.78% |
Profit Margin | -70.21% |
EBITDA Margin | -61.74% |
EBIT Margin | -65.49% |
FCF Margin | -43.37% |
Dividends & Yields
LAB does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.09% |
Shareholder Yield | -1.09% |
Earnings Yield | -7.26% |
FCF Yield | -4.48% |
Analyst Forecast
The average price target for LAB is $4.00, which is 48.42% higher than the current price. The consensus rating is "Buy".
Price Target | $4.00 |
Price Target Difference | 48.42% |
Analyst Consensus | Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
LAB has an Altman Z-Score of -0.68 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.68 |
Piotroski F-Score | 4 |